FindTrial
Sign In

Study on the Effect of Different Acupoint Selection Protocols of Transcutaneous Electrical Acupoint Stimulation in Preventing Postoperative Nausea and Vomiting After Day Surgery Laparoscopic Cholecystectomy

Study on the Effect of Different Acupoint Selection Protocols of Transcutaneous Electrical Acupoint Stimulation in Preventing Postoperative Nausea and Vomiting After Day Surgery Laparoscopic Cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002006
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-10-20
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Day Surgery Laparoscopic Cholecystectomy

Interventions

Ondansetron + Multiple Acupoints Group:Based on the theory of "Yu-Mu acupoint pairing" from traditional Chinese medicine TEAS intervention is conducted on bilateral Danyu (BL19) Riyue (GB24) and Neigu
Ondansetron Group:routinely administering 8mg of ondansetron oral soluble film until dissolved for postoperative nausea and vomiting prevention
Ondansetron + Neiguan (PC6) Group:Select bilateral Neiguan (PC6) acupoints. Utilize the SDZ-III TEAS device to administer TEAS intervention with a dense-sparse wave of 2/100 Hz 30 minutes before surg

Sponsors

Day Surgery Center of General Practice Medical Center/West China School of Nursing West China Hospital Sichuan University Chengdu 610041 China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Patients who meet the surgical indications for day surgery laparoscopic cholecystectomy; 2.Aged between 18 and 65 years; 3.Classified as American Society of Anesthesiologists (ASA) physical status I–II; 4.Apfel score between 2 and 4; 5.Willing to participate in the study and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Local skin damage infection or dermatitis at the acupoint site; 2.Patients with implanted cardiac pacemakers or electronic medical devices; 3.Unable to cooperate in completing questionnaire assessments.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative nausea and vomiting within 24 hours after surgery;—

Secondary

MeasureTime frame
the incidence and severity of postoperative nausea and vomiting within 48/72 hours after surgery;the utilization rate of rescue antiemetic medication within 72 hours after surgery;Severity of postoperative nausea and vomiting within 24 hours after surgery;Incidence of transcutaneous electrical acupoint stimulation-related adverse events within 72 hours postoperatively;postoperative recovery quality;time of first flatus/defecation after surgery;—

Countries

China

Contacts

Public ContactHuang Mingjun

Day Surgery Center of General Practice Medical Center/West China School of Nursing West China Hospital Sichuan University Chengdu 610041 China

huangmingjun@wchscu.cn18980606989

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026